SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Interim trading statement

3 Aug 2017 07:00

RNS Number : 9666M
Ebiquity PLC
03 August 2017
 

Ebiquity Plc

("the Company")

 

 

Interim trading statement

 

 

Ebiquity plc, the leading independent marketing analytics specialists, today announces its trading statement for the 6 months ended 30 June 2017 ("the period").

 

Ebiquity's total revenues have grown by 5% over the period, with operating profit and earnings anticipated to be in line with market expectations.

 

During the period we continued to deliver against the milestones set out within our Growth Acceleration Plan. As planned, we organically expanded our Marketing Effectiveness practice into Europe and Asian markets, recruited dedicated business development staff in selected markets, and invested into internal support functions.

 

Additionally we launched the Ebiquity "Media Transparency Score" to help advertisers understand how well their business operations perform in achieving the level of media transparency they desire from their marketing activities, and "Total View Attribution" which enables clients to improve the return on investment of their media, by enabling them to understand which media channels and campaigns (both online and offline in combination) are the most effective and warrant increased investment.

 

Revenues from the Media Value Measurement ("MVM") practice achieved high single digit growth, benefitting from strong performance from our Contract Compliance business as clients are more focused on achieving media transparency. However, the performance of our US MVM business was softer than anticipated during the period, due to a lower rate of client renewals. We are in the process of strengthening our US team in response to these changing client demands.

 

The Market Intelligence ("MI") practice revenues from our platform business (Portfolio), which accounts for over 90% of MI revenue, increased over the period. We launched our Portfolio Digital service in Asia Pacific and Europe, which combined with high renewal rates, has driven a return to revenue growth. As expected, revenue from our project based reputation business declined in the first half.

 

Within the Marketing Performance Optimization ("MPO") practice our Marketing Effectiveness revenues continued to grow, most notably from our UK business. Additionally, during the first half of the year in line with our Growth Acceleration Plan we recruited Marketing Effectiveness practice leaders in Germany, France and Singapore. Performance from our US based Multi-Channel Analytics practice fell behind expectations due to organisational changes at some of our largest clients.

 

Whilst the first half of the year has been softer in the US, we anticipate stronger performance from the US MPO and MVM in the second half of the year and we are pleased that the MI practice has returned to growth following high renewal rates and new product launches. Management anticipate that full year trading will be broadly in line with market expectations.

 

The Company will release its interim report for the 6 months ended 30 June 2017 on 26 September 2017.

3 August 2017

Enquiries:

 

Ebiquity plc

Michael Karg (CEO)

Andrew Noble (CFO)

 

020 7650 9600

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

020 7457 2020

 

Numis Securities Limited

Nick Westlake (NOMAD)

Toby Adcock (Corporate Broker)

 

020 7260 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGGRMZFGNZZ
Date   Source Headline
8th Sep 20087:00 amRNSAGM Statement
29th Aug 200810:23 amRNSTotal Voting Rights
7th Aug 20081:33 pmRNSHolding(s) in Company
7th Aug 20087:00 amRNSChange of Name to Ebiquity
28th Jul 20082:05 pmRNSHolding(s) in Company
23rd Jul 20087:00 amRNSFinal Results
11th Jun 20084:00 pmRNSHolding(s) in Company
3rd Jun 20087:00 amRNSTrading Statement
7th May 20084:10 pmRNSHolding(s) in Company
25th Apr 20087:00 amRNSStrategy update
24th Apr 20087:01 amRNSBoard appointment
3rd Apr 20088:41 amRNSDirector/PDMR Shareholding
12th Mar 200810:32 amRNSHolding(s) in Company
29th Feb 200812:15 pmRNSHolding(s) in Company
22nd Feb 20081:11 pmRNSDirectorate Change
6th Feb 20083:47 pmRNSHolding(s) in Company
4th Feb 20082:07 pmRNSHolding(s) in Company
4th Feb 20082:05 pmRNSHolding(s) in Company
24th Jan 20087:01 amRNSDirector/PDMR Shareholding
23rd Jan 20087:02 amRNSInterim Results
10th Jan 200810:11 amRNSNotice of Results
7th Dec 20073:39 pmRNSHolding(s) in Company
7th Dec 20079:17 amRNSHolding(s) in Company
8th Nov 20071:14 pmRNSHolding(s) in Company
31st Oct 20072:59 pmRNSTotal Voting Rights
29th Oct 20073:07 pmRNSAdditional Listing
29th Oct 20078:56 amRNSAdditional Listing
11th Oct 200712:35 pmRNSDirector/PDMR Shareholding
2nd Oct 20074:27 pmRNSDirector/PDMR Shareholding
28th Sep 20073:51 pmRNSTotal Voting Rights
27th Sep 20077:01 amRNSBoard Changes
21st Sep 200711:31 amRNSAdditional Listing
14th Sep 20072:42 pmRNSHolding in US Operation
6th Sep 200710:36 amRNSAGM Statement
15th Aug 20074:39 pmRNSAIM Rule 26
15th Aug 20078:00 amRNSChange of Adviser
24th Jul 20077:00 amRNSFinal Results
16th Jul 20072:41 pmRNSNotice of Results
10th Jul 20074:02 pmRNSNotice of Results
4th May 20077:01 amRNSDirector Shareholding
3rd May 200711:44 amRNSMarketing Spend Q1 07
3rd May 20079:58 amRNSHolding(s) in Company
2nd May 200711:55 amRNSGrant of Share Options
30th Apr 20077:03 amRNSSecond Interim Results
18th Apr 20077:01 amRNSBoard Appointment
10th Apr 20073:44 pmRNSNotice of Results
21st Mar 20073:01 pmRNSHolding(s) in Company
21st Mar 20072:57 pmRNSHolding(s) in Company
21st Mar 20072:44 pmRNSHolding(s) in Company
8th Mar 20077:01 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.